BIOCAD unveil breakthrough COVID 19 drug
BIOCAD have developed a medicine which can alleviate the worst symptoms of COVID-19 infection without side effects.
Levilimab, originally intended to treat rheumatoid arthritis, has received official approval and is expected to appear in hospitals as early as July.